Milk A1 β-casein and health-related outcomes in humans: a systematic review
- 5 February 2019
- journal article
- review article
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 77 (5) , 278-306
Abstract
Various epidemiological studies suggest a positive association between exposure to cow's milk A1 β-casein protein and risk for noncommunicable chronic diseases. The consumption of A2 cow's milk is increasing, likely because A2 milk is postulated to have positive effects on digestive health. A systematic review was conducted to investigate associations between A1 β-casein and health-related outcomes in humans. Five electronic databases, 3 clinical trial registries, and the internet were searched systematically. Using predefined inclusion criteria, 2 authors independently selected studies investigating the effect of A1 β-casein or β-casomorphin-7 intake/exposure on any health-related outcome in humans. Discrepancies were resolved by consensus. Two authors independently extracted data and assessed risk of bias. The certainty of evidence per outcome was evaluated using the GRADE approach. Discrepancies were resolved by consensus. Fifteen randomized controlled trials, 2 case-control studies, and 8 ecological studies were included. Most randomized controlled studies and case-control studies investigating a potential effect on various outcomes were based on intermediate markers and found no significant difference between the 2 milk types. In contrast, most ecological studies reported that population-level A1 β-casein exposure is associated with adverse health outcomes. The certainty of the evidence for the included outcomes, as assessed by the GRADE approach, was rated as moderate for digestive symptoms and as low to very low for all other outcomes. Human-based evidence from clinical trials and epidemiological studies published prior to October 2017 provides moderate certainty for adverse digestive health effects of A1 β-casein compared with A2 β-casein but low or very low certainty for other health effects. These conclusions may change in the future, given the emergent nature of this topic and the ongoing research in this area. PROSPERO registration number CRD42016043795.Keywords
Funding Information
- Bavarian State Ministry for Food, Agriculture, and Forestry (7627.1–1/80)
This publication has 22 references indexed in Scilit:
- Does Milk Cause Constipation? A Crossover Dietary TrialNutrients, 2013
- Association between Dairy Food Consumption and Risk of Myocardial Infarction in Women Differs by Type of Dairy FoodThe Journal of Nutrition, 2013
- GRADE-Leitlinien: 1. Einführung – GRADE-Evidenzprofile und Summary-of-Findings-TabellenZeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 2012
- Bovine milk in human nutrition – a reviewLipids in Health and Disease, 2007
- A comparison of the effects of A1 and A2 β-casein protein variants on blood cholesterol concentrations in New Zealand adultsAtherosclerosis, 2006
- Lower Consumption of Cow Milk Protein A1 β-Casein at 2 Years of Age, Rather than Consumption among 11- to 14-Year-Old Adolescents, May Explain the Lower Incidence of Type 1 Diabetes in Iceland than in ScandinaviaAnnals of Nutrition and Metabolism, 2006
- Effect of dietary supplementation with βcasein A1 or A2 on markers of disease development in individuals at high risk of cardiovascular diseaseBritish Journal of Nutrition, 2006
- The A2 milk case: a critical reviewEuropean Journal of Clinical Nutrition, 2005
- β-casein A1, ischaemic heart disease mortality, and other illnessesMedical Hypotheses, 2001
- Evidence based medicine: what it is and what it isn'tBMJ, 1996